Technology | Oncology Information Management Systems (OIMS)

RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

Time July 13, 2018
Home
News | Breast Imaging

July 13, 2018 — Follow-up imaging for women with non-metastatic breast cancer varies widely across the country ...

Time July 13, 2018
Home
News | Stroke

iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular imaging analysis platform in Australia and New Zealand. Hospitals and clinics that treat ischemic stroke in these countries will now have access to RAPID’s automated computed tomography perfusion (CTP), magnetic resonance (MR), CT angiography (CTA) and ASPECTS solutions, with support from DIA’s customer service specialists in the region.

Time July 13, 2018
Home
Feature | Clinical Decision Support | Nathan Baugh

On July 12, the Centers for Medicare and Medicaid Services (CMS) released the proposed rule for the 2019 Physician Fee ...

Time July 13, 2018
Home
Technology | Ultrasound Imaging

July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia. The ...

Time July 12, 2018
Home
Technology | Ultrasound Imaging

EchoNous has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. Developed for usage across a wide range of patients including both adults and children, EchoNous Vein provides immediate, clear images at depths from 1 to 5 centimeters for quickly visualizing superficial and deeper veins with just two-button controls. EchoNous Vein will integrate with the company’s existing intelligent medical tool, Uscan, to form the EchoNous platform.

Time July 12, 2018
Home
News | Proton Therapy

Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new therapies with great potential actually have clear benefits over usual care for patients. However, the seven randomized trials funded by the National Cancer Institute (NCI) and the Patient Centered Outcomes Research Institute (PCORI) to test proton therapy are enrolling more slowly than expected. Commercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy. That’s the message from an expert at the Perelman School of Medicine at the University of Pennsylvania and colleagues at the NCI who are calling attention to what the authors say is a major barrier these trials face. The authors publish their commentary, and proposed solutions, this week in the Journal of Clinical Oncology.

Time July 12, 2018
Home
Technology | Computed Tomography (CT)

Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary Calcium Scoring algorithm. The algorithm, capable of automatically calculating a patient’s Agatston equivalent coronary calcium score from an electrocardiogram (ECG)-gated computed tomography (CT) scan, provides physicians with important data used in the assessment of the risk for coronary artery disease.

Time July 12, 2018
Home
News | Mammography

Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is the first dedicated mobile mammography provider to adopt VolparaEnterprise software to help deliver high-quality, personalized breast cancer screening. Invision Diagnostics performs over 8,000 mammograms annually in three advanced mobile mammography coaches in Asheville, Charlotte, Raleigh, and other locations throughout the Southeast.

Time July 11, 2018
Home
News | Women's Health

A new commentary appearing in the July issue of Cancer Causes & Control points to evidence that social factors help determine people’s vulnerability to cancer. The commentary, by scientists from the Bloomberg School, also argues that these factors should be considered routinely in studies and risk assessments that bear on clinical care.

Time July 11, 2018
Home
News | Radiation Therapy

Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to explore the production of the medical radioisotope no-carrier-added (n.c.a.) Lutetium-177. Lutetium-177 is used in targeted radionuclide therapy to treat cancers like neuroendocrine tumors and prostate cancer. It destroys cancer cells while leaving healthy cells unaffected.

Time July 11, 2018
Home
Technology | Ultrasound Women's Health

Hologic’s new Viera portable breast ultrasound system is now available for purchase in the United States and Europe. Delivering what the company calls exceptional image quality at the point of care, the Viera wireless ultrasound scanner provides physicians with the opportunity for earlier diagnoses and an optimized clinical workflow.

Time July 11, 2018
Home
News | Clinical Decision Support

Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an artificial intelligence (AI) software solution to support liver cancer diagnostics. The AI software will focus on utilizing computed tomography (CT) and magnetic resonance imaging (MRI), and care.

Time July 10, 2018
Home
News | Computed Tomography (CT)

The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center (UTHSC) as the first mobile stroke unit in the world to achieve IAC Computed Tomography (CT) accreditation. A three-year accreditation in the areas of Neurological CT/Acute Stroke and Vascular CTA (Computed Tomography Angiography) was awarded to the UTHSC Mobile Stroke Unit in May 2018.

Time July 09, 2018
Home
Technology | Ultrasound Imaging

South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U.S. Food and Drug Administration (FDA) approval. The Sonon 300L is designed to help primary care providers (PCPs) be more efficient and effective, with instant insight to diagnose or refer a patient to a specialist. The system provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes, according to the company.

Time July 09, 2018
Home
Sponsored Content | Case Study | PACS

One of the Northeast’s major teaching hospitals is an international leader in virtually every area of medicine. It has been the site of pioneering breakthroughs that have improved lives and advanced healthcare around the world. This hospital includes more than 100 outpatient practices with more than 1,000 physicians serving patients from New England, across the United States, and from more than 100 countries around the world.

Time July 09, 2018
Home
Sponsored Content | Whitepapers | PACS

The move toward value-based reimbursement (VBR) models is putting pressure on healthcare organizations to modernize their IT systems so they can more effectively measure and improve the quality and efficiency of their care. The long-term goal is clear. Organizations need to integrate their devices, applications, and data so that clinicians and administrators have the right information at the right time to deliver the best possible outcomes at the lowest possible cost.

Time July 09, 2018
Home
News | Treatment Planning

MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment planning system in combination with Mevion’s Hyperscan pencil beam scanning system. This was the world’s first treatment carried out on the Mevion S250i Proton Therapy System, according to Mevion.

Time July 05, 2018
Home
News | Magnetic Resonance Imaging (MRI)

Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in teeth, according to a new study appearing online in the journal Radiology. The effect was not seen, however, in the lower strength, more commonly used 1.5-Tesla (T) MRI.

Time July 05, 2018
Home
Feature | Breast Imaging | By Jeffrey Hoffmeister, M.D.

When women reach age 40, an annual mammogram becomes a necessary part of their healthcare ritual — regardless if they have a predisposition to or symptoms of breast cancer. But mammograms are not the only tools in which doctors rely. Other technologies, including magnetic resonance imaging (MRI), are proving valuable for screening, diagnosing and monitoring breast cancer, adding more weapons to the arsenal for both detecting and fighting the disease.

Time July 05, 2018
Home
Subscribe Now